Phages inject their DNA into the bacterial cell, multiply to large numbers using the resources of the host, and then burst out to infect more bacteria in the vicinity. Essentially, they are a ...

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...

Preclinical data support a novel combination of MB-101 (IL13Ra2-targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) to optimize clinical results FDA previously granted Orphan Drug ...

Hemifusomes are fused vesicles, or sacs of fluid, that were previously unknown to exist inside cells. They were discovered ...

In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

In their latest research, the scientists used EVE-Vax to design 83 brand-new versions of the "spike" protein on SARS-CoV-2, which is the main surface protein the virus uses to infect human cells.

However, this stalk is coated with chains of sugar molecules called glycans from the host’s cells. And the sugar coating keeps antibodies from recognizing, and therefore inactivating, the virus.

The low-mutation region that Wong’s team chose to target for the new vaccine is within the stalk region of the virus’ spike protein. However, this stalk is coated with chains of sugar molecules called ...

- ICVB-1042 is an Oncolytic Virus Engineered to Selectively Destroy Cancer Cells While Retaining Potency and Trigger a Robust Immune Response - Strategic Research Collaborations Focused on ...

Later, immune cells use these proteins to produce antibodies that will block the actual virus' spike proteins from binding to people's cells and infecting them.

Health COVID-19 virus could attack cancer cells and shrink tumors, new study suggests The early-stage research focused only on animal models, but scientists say it ‘offers hope’ ...